Condition
Appendiceal Adenocarcinoma
Total Trials
4
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 1 (2)
Trial Status
Recruiting3
Terminated1
Clinical Trials (4)
Showing 4 of 4 trials
NCT06399757Phase 1Recruiting
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors
NCT05947838Not ApplicableRecruitingPrimary
A Prospective Feasibility Study Using ctDNA to Tailor Neoadjuvant Chemotherapy for Patients With Colorectal or Appendiceal Adenocarcinoma
NCT05734430Recruiting
Genetics of Appendix Cancer Study
NCT04665921Phase 1Terminated
A Study of SGN-STNV in Advanced Solid Tumors
Showing all 4 trials